Develop a framework for risk stratification for lung cancer and screening. Develop a strategy for the initial evaluation of suspected lung cancer. Compare and contrast NSCLC and SCLC prognosis and treatments.
Identify the pathogenesis of AML. Diagnose AML using common clinical/laboratory findings and its four main complications.
Learn to diagnose and treat the most common myeloproliferative disorders. Develop a differential for polycythemia, thrombocytosis, and leukocytosis.
Identify common types of checkpoint inhibitors and their indications then use the NCCN guidelines to address common side effects. (20 min)
Develop a framework for both underproduction and overproduction anemia, then reinforce the framework through short clinical cases (60 min).